000			01657 a2200469 4500
005			20250513030255.0
264		0	_c19960118
008			199601s 0 0 eng d
022			_a0803-7051
024	7		_a10.3109/08037059509077602 _2doi
040			_aNLM _beng _cNLM
100	1		_aSihm, I
245	0	0	_aNormalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE-inhibitor perindopril. _h[electronic resource]
260			_bBlood pressure _cJul 1995
300			_a241-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use
650	0	4	_aAntihypertensive Agents _xtherapeutic use
650	0	4	_aArteries _xanatomy & histology
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHydralazine _xtherapeutic use
650	0	4	_aHypertension _xcomplications
650	0	4	_aHypertrophy, Left Ventricular _xdrug therapy
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aIsradipine _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPerindopril
650	0	4	_aVascular Resistance _xdrug effects
700	1		_aSchroeder, A P
700	1		_aAalkjaer, C
700	1		_aHolm, M
700	1		_aMørn, B
700	1		_aMulvany, M
700	1		_aThygesen, K
700	1		_aLederballe, O
773	0		_tBlood pressure _gvol. 4 _gno. 4 _gp. 241-8
856	4	0	_uhttps://doi.org/10.3109/08037059509077602 _zAvailable from publisher's website
999			_c7496031 _d7496031